A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

HER3-DXd demonstrated activity in a phase 3 trial of patients with previously treated, EGFR-mutant NSCLC, but the BLA for HER3-DXd has been withdrawn.

Researchers found that colibactin-induced mutational signatures were enriched in early-onset colorectal cancer cases.

Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.

Children with ALL who were overweight or obese at 2 or more time points had an increased risk of relapse and death.

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

Adjuvant cemiplimab could be a new standard of care for patients with cutaneous squamous cell carcinoma at high risk of recurrence, according to Danny Rischin, MD.

This is not the first trial to show a lack of benefit when adding immunotherapy to SBRT in patients with early-stage, inoperable NSCLC.

Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

HealthDay News — Rates of colorectal cancer detection through colonoscopy screening are similar for adults aged 45 to 49 years and 50 to 54 years, according to a research letter published online ...

Radiotherapy is a cornerstone of prostate cancer treatment. Moderately hypofractionated radiotherapy (MHFRT) is advancing this care by delivering higher radiation doses per fraction over fewer ...